Plasma fatty acid composition in continuous ambulatory peritoneal dialysis patients: An increased omega-6/omega-3 ratio and deficiency of essential fatty acids

Renal Failure

Volumn 33, Issue 8, 2011, Pages 819-823

  Yerlikaya, Fatma Hümeyra ^a   Mehmetoglu, Idris ^a   Kurban, Sevil ^a   Tonbul, Zeki ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Desaturase activity; Elongase activity; Essential fatty acids; Omega 3 fatty acids; Omega 6 fatty acids; Peritoneal dialysis

Indexed keywords

10 HEPTADECANOIC ACID; 10 PENTADECANOIC ACID; 11,14 EICOSEDIENOIC ACID; 15 TETRACOSENOIC ACID; ACYL COENZYME A DESATURASE; ALBUMIN; ARACHIDONIC ACID; C REACTIVE PROTEIN; CALCIUM; CHOLESTEROL; DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; HEMOGLOBIN; HENICOSANOIC ACID; LAURIC ACID; LINOLENIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; MYRISTIC ACID; MYRISTIOLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PARATHYROID HORMONE; PHOSPHATE; SATURATED FATTY ACID; TRIACYLGLYCEROL; TRICOSANOIC ACID; UNCLASSIFIED DRUG; UNINDEXED DRUG; URIC ACID;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL DEFICIENCY; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ADULT; AGED; FATTY ACIDS, ESSENTIAL; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; YOUNG ADULT;

EID: 80052199857     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2011.601831     Document Type: Article

References (20)

1. Gokal R, Mallick NP. Peritoneal dialysis. Lancet. 1999;353:823-828. (Pubitemid 29110418)
2. Chiu YW, Mehrotra R. Can we reduce the cardiovascular risk in peritoneal dialysis patients? Indian J Nephrol. 2010;20: 59-67.
3. Ristić V, Tepsić V, Ristić-Medié D, et al. Plasma and erythrocyte phospholipid fatty acids composition in Serbian hemodialyzed patients. Ren Fail. 2006;28:211-216. (Pubitemid 43995103)
4. Hassan KS, Hassan SK, Hijazi EG. Effects of omega-3 on lipid profile and inflammation markers in peritoneal dialysis patients. Ren Fail. 2010;32:1031-1035.
5. Kawashima A, Sugawara S, Okita M, et al. Plasma fatty acid composition, estimated desaturase activities and intakes of energy and nutrient in Japanese men with abdominal obesity or metabolic syndrome. J Nutr Sci Vitaminol. 2009;55: 400-406.
6. Oda E, Hatada K, Kimura J. Relationships between serum unsaturated fatty acids and coronary risk factors: Negative relations between nervonic acid and obesity-related risk factors. Int Heart J. 2005;46:975-985.
7. Lagerstedt SA, Hinrichs DR, Batt SM. Quantitative determination of plasma C8-C26 total fatty acids for the biochemical diagnosis of nutritional and metabolic disorders. Mol Genet Metab. 2001;73:38-45. (Pubitemid 34177622)
8. Haugaard SB, Madsbad S, Hoy CE. Dietary intervention increases n-3 long-chain polyunsaturated fatty acids in skeletal muscle membrane phospholipids of obese subjects. Implications for insulin sensitivity. Clin Endocrinol. 2006;64:169-178.
9. Rifai N, Bachorik PS, Albers JJ. Lipids, lipoproteins and apolipoproteins. In: Burtis CA, Ashwood ER, eds. Tietz Textbook of Clinical Chemistry. Philadelphia, PA: W.B. Saunders Company; 1999:843-844.
10. de Gómez Dumm NT, Giammona AM, Touceda LA, Raimondi C. Lipid abnormalities in chronic renal failure patients undergoing hemodialysis. Medicina (B Aires). 2001;61: 142-146. (Pubitemid 33622303)
11. Nakamura N, Fujita T, Kumasaka R, et al. Serum lipid profile and plasma fatty acid composition in hemodialysis patients -Comparison with chronic kidney disease patients. In Vivo. 2008;22:609-611.
12. Dasgupta A, Kenny MA, Ahmad S. Abnormal fatty acid profile in chronic hemodialysis patients: Possible deficiency of essential fatty acids. Clin Physiol Biochem. 1990;8:238-243.
13. Girelli D, Lupo A, Trevisan MT, et al. Red blood cell susceptibility to lipid peroxidation, membrane lipid composition, and antioxidant enzymes in continuous ambulatory peritoneal dialysis patients. Perit Dial Int. 1992;12:205-210.
14. Friedman AN, Moe SM, Perkins SM, Li Y, Watkins BA. Fish consumption and omega-3 fatty acid status and determinants in long-term hemodialysis. Am J Kidney Dis. 2006;47: 1064-1071. (Pubitemid 43767330)
15. Peck LW, Monsen ER, Ahmad S. Effect of three sources of long-chain fatty acids on the plasma fatty acid profile, plasma prostaglandin E2 concentrations, and pruritus symptoms in hemodialysis patients. Am J Clin Nutr. 1996;64: 210-214. (Pubitemid 26250841)
16. Varga Z, Kárpáti I, Paragh G, Buris L, Kakuk G. Relative abundance of some free fatty acids in plasma of uremic patients: Relationship between fatty acids, lipid parameters, and diseases. Nephron. 1997;77:417-421. (Pubitemid 27511192)
17. Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med. 2008;233:674-688.
18. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2003;23:20-30.
19. Gebauer SK, Psota TL, Harris WS, Kris-Etherton PM. n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr. 2006;83:1526-1535.
20. de Gómez Dumm NT, Giammona AM, Touceda LA, Raimondi C. Lipid abnormalities in chronic renal failure patients undergoing hemodialysis. Medicina. 2001;61: 142-146. (Pubitemid 33622303)